ICICI Securities has reiterated a BUY call on Titan Company, assigning a 12-month target price of Rs4,980 against the current market price of Rs4,

Jubilant Pharmova’s December quarter results reinforce a steady growth narrative even as near-term margin pressures temper earnings momentum.

Exide Industries is entering a decisive phase in its multi-year transformation.

Mahindra Lifespace Developers has reached a long-awaited inflection point.

ICICI Securities has reiterated a BUY call on Hyundai Motor India (HMIL), citing resilient execution in Q3FY26 despite near-term margin pressures linked to capacity expansion.

IDFC First Bank is entering a decisive phase of operational maturity as margin expansion, disciplined balance-sheet growth, and easing asset-quality pressures converge.